Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey (Q46435130)

22 December 2017

title

Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey (English)

1 reference

22 December 2017

main subject

heart failure

0 references

chronic heart failure

1 reference

7

Luigi Tavazzi

1 reference

22 December 2017

1

Michel Komajda

1 reference

22 December 2017

Dirk J van Veldhuisen

5

object named as

Dirk J van Veldhuisen

1 reference

22 December 2017

author name string

Pablo Lapuerta

2

1 reference

22 December 2017

Nancy Hermans

3

1 reference

22 December 2017

José Ramon Gonzalez-Juanatey

4

1 reference

22 December 2017

Erland Erdmann

6

1 reference

22 December 2017

Philip Poole-Wilson

8

1 reference

22 December 2017

Claude Le Pen

9

1 reference

22 December 2017

publication date

12 April 2005

1 reference

22 December 2017

published in

European Heart Journal

1 reference

22 December 2017

volume

26

1 reference

22 December 2017

issue

16

1 reference

22 December 2017

page(s)

1653-1659

1 reference

22 December 2017

The current cost of heart failure to the National Health Service in the UK.

cites work

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

Guidelines for the diagnosis and treatment of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

A new approach for measuring quality of care for women with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

Determinants of mortality in elderly patients with heart failure: the role of angiotensin-converting enzyme inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

Heart failure mortality among older Medicare beneficiaries: association with left ventricular function evaluation and angiotensin-converting enzyme inhibitor use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

Differences in generalist and specialist physicians’ knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

Improving care for patients with chronic heart failure in the community: the importance of a disease management program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

The benefit of implementing a heart failure disease management program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

Ambulatory heart failure management in private practice in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/EURHEARTJ/EHI251

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHI251

1 reference

22 December 2017

1 reference

22 December 2017